SCHEMBL9611269

SCHEMBL9611269

CC(C)(C)C(=O)Nc1ccc2ccccc2c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.62
RAB9A P51151 7/20 0.59
NPC1 O15118 6/20 0.59
MAPT P10636 3/20 0.59
MEN1 O00255 4/20 0.58
KMT2A Q03164 4/20 0.58
CYP1A2 P05177 2/20 0.58
KDM4E B2RXH2 1/20 0.58
ALDH1A1 P00352 1/20 0.58
CYP2C19 P33261 1/20 0.58
HIF1A Q16665 1/20 0.58
LCK P06239 1/20 0.58
CTSL P07711 1/20 0.58
PTPRC P08575 1/20 0.58
PTPN2 P17706 1/20 0.58
PTPN1 P18031 1/20 0.58
CTSS P25774 1/20 0.58
PTPN13 Q12923 1/20 0.58
HDAC1 Q13547 2/20 0.57
HDAC7 Q8WUI4 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30453039 1.00 L3MBTL1 (0.62) L3MBTL1RAB9ANPC1MAPTMEN1
SCHEMBL8897654 0.96 L3MBTL1 (0.62) L3MBTL1RAB9ANPC1MAPTMEN1
SCHEMBL7781162 0.88 RAB9A (0.57) L3MBTL1RAB9ANPC1MAPTMEN1
SCHEMBL19335548 0.84 L3MBTL1 (0.60) L3MBTL1MAPTMEN1KMT2AKDM4E
SCHEMBL14571969 0.84 RAB9A (0.61) L3MBTL1RAB9ANPC1MAPTMEN1
SCHEMBL12507949 0.83 MEN1 (0.56) L3MBTL1RAB9ANPC1MAPTMEN1
SCHEMBL6638890 0.83 LMNA (0.55) L3MBTL1RAB9ANPC1MAPTMEN1
SCHEMBL25898897 0.83 L3MBTL1 (0.58) L3MBTL1RAB9ANPC1MAPTMEN1
SCHEMBL5549552 0.82 HDAC1 (0.70) L3MBTL1RAB9ANPC1MAPTMEN1
Anthracene SCHEMBL29076817 0.81 MEN1 (0.67) L3MBTL1RAB9ANPC1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113912529-B Method for synthesizing indole compounds by catalyzing N-aryl amide compounds and vinylene carbonate with ruthenium 成都大学 2023-07-25 CN disclosed
CN-116178299-A Preparation method of 4H-benzo [ d ] [1,3] oxazin-4-one compound 南京大学 2023-05-30 CN disclosed
CN-113912529-A Method for synthesizing indole compound by catalyzing N-aryl amide compound and vinylene carbonate with ruthenium 成都大学 2022-01-11 CN disclosed
US-10173980-B2 Mixed disulfide conjugates of thienopyridine compounds and uses thereof THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2019-01-08 US disclosed
US-20180155289-A1 MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2018-06-07 US disclosed
US-20180155289-A1 MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2018-06-07 US disclosed
US-8530456-B2 Sonic hedgehog modulators PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2013-09-10 US disclosed
US-8415486-B2 IAP inhibitors TETRALOGIC PHARMACEUTICALS CORP. (US) 2013-04-09 US disclosed
US-8415486-B2 IAP inhibitors TETRALOGIC PHARMACEUTICALS CORP. (US) 2013-04-09 US disclosed
US-20120135990-A1 IAP INHIBITORS TETRALOGIC PHARMACEUTICALS CORP. (US) 2012-05-31 US disclosed
US-20110172233-A1 SONIC HEDGEHOG MODULATORS MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2011-07-14 US disclosed
US-20110028509-A1 Sulfonamides MERCK SERONO SA (CH) 2011-02-03 US disclosed
US-7244847-B2 Benzimidazole compounds ISIS PHARMACEUTICALS, INC. (US) 2007-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110172233-A1 SONIC HEDGEHOG MODULATORS SHH, GLI1, SMO L3MBTL1 1133/4885RAB9A 1847/4885NPC1 2394/4885
US-20120135990-A1 IAP INHIBITORS XIAP, IAPP, BIRC5 L3MBTL1 3151/4885RAB9A 1074/4885NPC1 757/4885
US-10173980-B2 Mixed disulfide conjugates of thienopyridine compounds and uses thereof TST, TXN, TXNRD2 L3MBTL1 3283/4885RAB9A 2782/4885NPC1 4250/4885
US-20180155289-A1 MIXED DISULFIDE CONJUGATES OF THIENOPYRIDINE COMPOUNDS AND USES THEREOF TST, TXN, TXNRD2 L3MBTL1 3283/4885RAB9A 2782/4885NPC1 4250/4885
US-20110028509-A1 Sulfonamides CXCR3, CXCR2, CXCR1 L3MBTL1 3680/4885RAB9A 2029/4885NPC1 4017/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.